Revive Therapeutics

Revive Therapeutics Gains 25% on Positive FDA Comments.

The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and...

Soona Amhaz, Bags $50 Million for New Crypto Fund

“I think it’s a phenomenal time to be investing,” Amhaz said. “This is the exact right time to be doubling down.”
Internet Stock Review

Internet Stock Review Relaunches After 23 Years.

Our First Broad Based Recommended Watch List in Over Two Decades! First name to our list of 20, is...

Bavarian Nordic (BVNRY) Bags $119 Million Order from Joe Biden.

We Were up 80% on Bavarian For a Little While There. The Stock Looks Better Today, Then When we Originally Added...

Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?

Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found...

Cybin (CYBN) and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s...

- Preliminary data confirm Flow's ability to successfully measure neuro-effect of ketamine over 10 days - - Results to...

Smart for Life (SMFL) Teams up With Diamond Creek Capital

IPO Buyers Liked it at $5.00. We Liked it at $0.85. We Love it at $0.55. LIVE...

Video Interview: Smart for Life (SMFL) CEO A.J. Cervantes.

Excellent interview. We were at the Noble Investor Conference to see it live. And we were at the manufacturing plant this Friday....

Report: Kerrisdale Capital on Up Fintech Holding (TIGR).

The Robinhood of China? If They Liked it at $18, They've got to Love it at $4.00!

New Report: Lion Group Holdings (LGHL) Initiating Coverage. $1.07

Massive Long-Term Potential from Singapore based Rising Fintech Star. A Fintech that nearly 'has it all' reported impressive...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!